Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Clene (CLNN) EBITDA (2020 - 2025)

Clene has reported EBITDA over the past 6 years, most recently at -$9.2 million for Q4 2025.

  • For Q4 2025, EBITDA rose 32.82% year-over-year to -$9.2 million; the TTM value through Dec 2025 reached -$26.1 million, up 34.04%, while the annual FY2025 figure was -$26.1 million, 34.04% up from the prior year.
  • EBITDA for Q4 2025 was -$9.2 million at Clene, down from -$8.8 million in the prior quarter.
  • Over five years, EBITDA peaked at $28.9 million in Q3 2021 and troughed at -$39.7 million in Q1 2021.
  • A 5-year average of -$7.7 million and a median of -$8.4 million in 2024 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: skyrocketed 380.36% in 2021 and later tumbled 980.88% in 2023.
  • Year by year, EBITDA stood at $4.5 million in 2021, then plummeted by 120.9% to -$931000.0 in 2022, then tumbled by 980.88% to -$10.1 million in 2023, then tumbled by 36.15% to -$13.7 million in 2024, then surged by 32.82% to -$9.2 million in 2025.
  • Business Quant data shows EBITDA for CLNN at -$9.2 million in Q4 2025, -$8.8 million in Q3 2025, and -$7.4 million in Q2 2025.